The FDA has approved Phoxillum replacement solution for use during continuous renal replacement therapy (CRRT). Phoxillum can replace plasma volume removed by ultrafiltration and correct electrolyte and acid-base imbalances. The solution also may be used in cases of drug poisoning when CRRT is selected to remove dialyzable substances. Prescription Phoxillum is approved for both pediatric…
Physicians provided details of the first successful delivery of renal replacement therapy (RRT) to a patient with Ebola.
Researchers find a greater than 50% reduction in end-stage renal disease risk compared with radical nephrectomy.
First in-human use of miniaturized machine shows good outcomes.
In congressional testimony, Sharon M. Moe, MD, proposes a federal prize competition.
More than 60% of patients had died within four years of entry into a clinical trial of different RRT intensities for acute kidney injury.
As a venue for presenting important research on kidney disease to the world, Kidney Week never disappoints.
Study demonstrated six- and 12-month survival rates of 58% and 49%, respectively.
PARIS—Primary care physicians who use a clinical decision support system (CDSS) may be able to avoid late referrals for renal replacement therapy (RRT), researchers reported at the 49th Congress of the European Renal Association-European Dialysis and Transplant Association.
PHILADELPHIA—Levels of fibroblast growth factor 23 (FGF-23) are elevated in acute kidney injury (AKI) and are associated with an increased risk of death or need for renal replacement therapy (RRT), data presented at Kidney Week 2011 suggest.
